Teva Pharmaceutical Industries' affiliate Teva Pharmaceuticals and Sanofi said Tuesday that duvakitug maintained clinically meaningful efficacy through 44 weeks in a Phase 2b long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results